Bringing the fundamentals into focus…
Back to CG Oncology, Inc.
How CG Oncology, Inc. stacks up
CGON · against 552 other Healthcare companies listed in US-listed
Overall
52/ 100
Above the middle of the pack.
Ranked #174 of 553 · scores higher than 66% of peers
Bars: peers in each 10-point band of the overall score96 peers with an overall score of 50–59, including CGON · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CGON| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 174 | 1.6B USD | 52 | 46 | 94 | 59 | 2 / 2 | |
| 174 | 1.2B USD | 52 | 85 | 33 | 67 | 2 / 2 | |
| 174 | 1.8B USD | 52 | 57 | 89 | 46 | 2 / 2 | |
| 174 | 58.6B USD | 52 | 58 | 56 | 85 | 2 / 2 | |
| 174 | 5.7B USD | 52 | 8 | 96 | 5 | 0 / 2 | |
| 174 | 5.1B USD | 52 | 42 | 85 | 47 | 2 / 2 | |
| 174 | 28.7B USD | 52 | 63 | 55 | 65 | 2 / 2 | |
| 174 | 4.8B USD | 52 | 69 | 51 | 66 | 2 / 2 | |
| 174 | 2.3B USD | 52 | 80 | 25 | 73 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score